Background Image
Table of Contents Table of Contents
Previous Page  41 / 132 Next Page
Information
Show Menu
Previous Page 41 / 132 Next Page
Page Background

2015 Annual Report

41

Controlled

Drugs

Management

Medical

Devices

Management

Risk Assessment

Management and

Research Outcomes

Cosmetics

Management

Appendix

National

Laboratory and

Testing Network

Risk Communication

and Consumer

Protection

International

Cooperation and

Cross-Strait Exchange

Food

Management

Medicinal

Products

Management

Policy and

Organization

4. Morphine Sulfate Sustained Release Film Coated (FC) Tablets 30mg wins the

SNQ Award

In 2014, identification barcodes for the smallest type of product packaging was updated from

bottles to blister packs. The product

Morphine Sulfate Sustained Release Tablets 30mg

was

subject to stringent and professional scientific validation and reviews conducted by the Symbol

of National Quality (SNQ) committee and was formally named as a certified quality product for the

pharmaceuticals / prescription medicine category in the

17

th

National Biotechnology & Medical

Care Quality Award

.

Section 3. Controlled Drug Alerts and Monitoring

Current Status

Abuse of illegal drugs may severely affect mental and physical health, and the issue is becoming a

growing challenge due to globalization and increasingly complex trends. Drug abuse also leads to

other issues such as reduced quality of the working population, increase in drug-related crime, impact

on economic development and public safety, and may even affect overall national competitiveness.

To establish a healthy society protected from hazardous drugs, illegal drug control strategies must

focus on prevention. Drug abuse reports must be actively compiled to establish robust early-warning

systems and functions and eliminate the spread of illegal drugs.

Policies and Outcomes

1. Collecting and Compiling National Drug Abuse Information

(1) To understand the state of drug abuse, drug types, and trends in the country, TFDA has a drug

abuse monitoring mechanism. Drug abuse information on the

Controlled Drug Abuse Reporting

System

(http://dars.fda.gov.tw/)

is compiled and analyzed on a monthly basis. Also, statistics

such as drug abuse urine tests, non-urine tests of suspected drugs and controlled drugs cases,

and discovery of illegal drugs in the Taiwan region are compiled to form the

Drug Abuse Case and

Testing Statistics

to achieve the purposes of monitoring and understanding the current state and

trends of drug abuse throughout the country.